HIGHLIGHTS
- who: Krystal Villalobos-Ayala and collaborators from the Department of Molecular Medicine, Morsani College of Medicine at the University of South Florida, Department of Immunology, HLee Moffitt Cancer Center, Tampa, FL, USA have published the research: Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer, in the Journal: (JOURNAL)
- what: The authors are the first to show that the bioflavonoid API reduces tumor-associated inflammatory factors, restores SHIP-1 expression and augments tumoricidal TAM, which corresponds with an increase in anti-tumor immune_responses in different pre-clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.